BG42676A3 - Method for preparang derivatives of 6- aminoalkyl- penicillanic acid - Google Patents

Method for preparang derivatives of 6- aminoalkyl- penicillanic acid

Info

Publication number
BG42676A3
BG42676A3 BG059284A BG5928483A BG42676A3 BG 42676 A3 BG42676 A3 BG 42676A3 BG 059284 A BG059284 A BG 059284A BG 5928483 A BG5928483 A BG 5928483A BG 42676 A3 BG42676 A3 BG 42676A3
Authority
BG
Bulgaria
Prior art keywords
derivatives
preparang
aminoalkyl
penicillanic acid
acid
Prior art date
Application number
BG059284A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wayne Barth
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/388,323 external-priority patent/US4427678A/en
Priority claimed from US06/434,371 external-priority patent/US4452796A/en
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG42676A3 publication Critical patent/BG42676A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG059284A 1982-01-11 1983-01-10 Method for preparang derivatives of 6- aminoalkyl- penicillanic acid BG42676A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33879782A 1982-01-11 1982-01-11
US38832482A 1982-06-14 1982-06-14
US06/388,323 US4427678A (en) 1982-01-11 1982-06-14 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
US06/434,371 US4452796A (en) 1982-06-14 1982-10-21 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Publications (1)

Publication Number Publication Date
BG42676A3 true BG42676A3 (en) 1988-01-15

Family

ID=27502592

Family Applications (1)

Application Number Title Priority Date Filing Date
BG059284A BG42676A3 (en) 1982-01-11 1983-01-10 Method for preparang derivatives of 6- aminoalkyl- penicillanic acid

Country Status (20)

Country Link
EP (1) EP0084925B1 (fr)
JP (1) JPH0689005B2 (fr)
AU (1) AU538468B2 (fr)
BG (1) BG42676A3 (fr)
CA (1) CA1190921A (fr)
DD (2) DD209462A5 (fr)
DE (1) DE3362826D1 (fr)
DK (1) DK166883B1 (fr)
ES (2) ES518912A0 (fr)
FI (1) FI79112C (fr)
GR (1) GR77152B (fr)
HU (1) HU189211B (fr)
IE (1) IE54390B1 (fr)
IL (1) IL67647A (fr)
NO (6) NO830046L (fr)
NZ (1) NZ202982A (fr)
PL (1) PL142315B1 (fr)
PT (1) PT76077B (fr)
RO (2) RO87705A (fr)
YU (1) YU43646B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499017A (en) * 1983-06-06 1985-02-12 Pfizer Inc. Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives
US4502990A (en) * 1983-06-06 1985-03-05 Pfizer Inc. Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
JPS60239489A (ja) * 1984-05-15 1985-11-28 Meiji Seika Kaisha Ltd ６−エピペニシリンスルホン化合物及びその製造方法
GB2206579B (en) * 1987-07-10 1991-05-29 Erba Farmitalia 6a and 6b-(substituted methyl)-penicillanic acid derivatives
WO2008141764A1 (fr) * 2007-05-21 2008-11-27 Hans Rudolf Pfaendler Composition pharmaceutique active anti-mrsa bactéricide contenant des carbapénèmes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors

Also Published As

Publication number Publication date
NO841068L (no) 1983-07-12
PL142315B1 (en) 1987-10-31
ES525238A0 (es) 1985-08-16
ES8403489A1 (es) 1984-03-16
RO84910B (ro) 1984-09-30
CA1190921A (fr) 1985-07-23
PT76077A (en) 1983-02-01
IE54390B1 (en) 1989-09-13
FI830081A0 (fi) 1983-01-10
DE3362826D1 (en) 1986-05-15
RO87705A (fr) 1985-10-31
IL67647A (en) 1986-08-31
NO833415L (no) 1983-07-12
GR77152B (fr) 1984-09-07
DK166883B1 (da) 1993-07-26
RO84910A (fr) 1984-08-17
DD209462A5 (de) 1984-05-09
JPS58126889A (ja) 1983-07-28
IL67647A0 (en) 1983-05-15
NZ202982A (en) 1986-04-11
NO830046L (no) 1983-07-12
JPH0689005B2 (ja) 1994-11-09
NO841070L (no) 1983-07-12
PL240108A1 (en) 1985-08-13
AU538468B2 (en) 1984-08-16
EP0084925B1 (fr) 1986-04-09
FI79112B (fi) 1989-07-31
RO87705B (ro) 1985-10-01
FI79112C (fi) 1989-11-10
YU43646B (en) 1989-10-31
NO841069L (no) 1983-07-12
FI830081L (fi) 1983-07-12
ES518912A0 (es) 1984-03-16
IE830042L (en) 1983-07-11
AU1023283A (en) 1983-07-21
HU189211B (en) 1986-06-30
YU4483A (en) 1986-02-28
DD218365A5 (de) 1985-02-06
EP0084925A1 (fr) 1983-08-03
DK7483D0 (da) 1983-01-10
DK7483A (da) 1983-07-12
PT76077B (en) 1986-01-09
ES8507147A1 (es) 1985-08-16
NO833416L (no) 1983-07-12

Similar Documents

Publication Publication Date Title
KR0145958B1 (en) Antibacterial agents
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
FI840748A (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen.
DE3785198D1 (de) Liposomes praeparat und antibiotikum.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
GR3006180T3 (fr)
BG37376A3 (en) Method for preparing salts of benzothiazine dioxide
SE9300758D0 (sv) Process for the production of clavulanic acid
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
BG42835A3 (en) Method for preparing derivatives of thiazolylacetic acid
AU564952B2 (en) N,n-dimethylglycine ester of metronidazole
ES8206530A1 (es) Un procedimiento para la preparacion de 1,1,1',1'-tetraoxidode penicilanato de penicilanoiloximetilo
BG42676A3 (en) Method for preparang derivatives of 6- aminoalkyl- penicillanic acid
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
ES8202561A1 (es) Un procedimiento para la produccion de 11,12-carbonato de eritromicilamina
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
NO872331D0 (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
ES8300773A1 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".
DE3567462D1 (en) -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8-substituted-1h,5h, benzo(ij)-quinoziline-2-carboxylic acids; their derivatives; and processes for producing the compounds
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
GR862698B (en) Cephalosporin derivatives and method for preparing them
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
ATE47863T1 (de) Makrolide derivate.